trial · primary record
Rina-S
Endometrial Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 660 |
| Primary completion | 2029-11 |
| Primary endpoint | Progression-free Survival (PFS) per Response Criteria in Solid Tumors (RECIST) v1.1, as Determined by Blinded Independent Central Review (BICR) |
| Registry ID | NCT07166094 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:06.876Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07166094
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Rina-S · compound